NCT06688968Recruiting
Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's Disease
Observational Pilot Study of Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's Disease. What Are the Effects of Mnestic or Hedonic Impairment on Emotion, Reminiscence and Musical Enjoyment
Source: ClinicalTrials.gov · Last updated 19 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this Multicenter observational pilot study is to Compare the specifics of musical engagement (behaviors related to music in everyday life) in subjects aged over 60 with Alzheimer s disease, Parkinson s disease and control subjects. The main questions it aims to answer are: 1. The description of different profiles of musical engagement in early-stage AD, in PD and in healthy elderly subjects. 2. The extent of executive, mnestic and hedonic dysfunctions will impact differently on emotional engagement, autobiographical evocation and sensitivity to musical reward, and will therefore enable distinct profiles to be drawn up. Participants will have an intervention consisting of an interview with a neuropsychologist lasting approximately 2 hours, including : * A semi-structured interview to check the participants eligibility and gather demographic data. * Neuropsychological tests and questionnaires will then be administered. * A relative of the study participant will help complete questionnaires.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 12 Nov 2024
- Start date
- 4 Feb 2025
- Primary completion date
- 1 Dec 2025
- Lead sponsor
- University Hospital, Montpellier
- Diseases
- Alzheimer disease, Parkinson disease
- NCT number
- NCT06688968
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 4 Feb 2025 to the primary completion date, 1 Dec 2025
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- No known neurological pathologies (epilepsy and other non-degenerative CNS diseases) or psychiatric disorders (chronic psychosis and psychotic episodes)
- Autistic disorders
- History of stroke or head trauma
- Unstable medical condition (cancer)
- Hearing impairment without hearing aids
Other
- Subject unable to read and/or write
- Refusal of consent after information
- Persons unable to give consent, research carried out in emergency situations, etc.)
- Non-affiliation with a social security scheme
- Person deprived of liberty (by judicial or administrative decision, or forced hospitalization)
- Person under legal protection (guardianship, curatorship, legal protection)
- Person participating in another research project with an exclusion period still in progress
Who the study is looking for
- General inclusion criteria:
- 60 years and older
- French-speaking and volunteering for the study
- Living at home with a relative
- Alzheimer's disease inclusion criteria:
- Biological diagnosis of probable Alzheimer's disease according to NINCDS-ADRDA criteria (McKhann et al., 1984)
- MMSE greater than or equal to 20
- Diagnosis of Idiopathic Parkinson's disease
- MMSE greater than or equal to 20
Age in the registry: 60 years to - · Sex: All · Accepts healthy volunteers
Sites (3)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Montpellier - CEPMo Coordinator of this site? Confirm its status | Montpellier | France | Recruiting |
| CHU de Montpellier - CMRR Coordinator of this site? Confirm its status | Montpellier | France | Not yet recruiting |
| Montpellier Seniors' Association Coordinator of this site? Confirm its status | Montpellier | France | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.